Aratana signs $37M licensing deal for pet cancer products

Aratana Therapeutics Inc. announced it has acquired the licensing rights to four products from Advaxis Inc...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.